South Korea DNA Synthesis Market Size, Share, and COVID-19 Impact Analysis, By Service Type (Gene Synthesis and Oligonucleotide Synthesis), By Application (Research Development and Diagnostics), By End-use (Biopharmaceutical & Diagnostics Companies, Academics & Research Institutes, and Contract Research Organizations), and South Korea DNA Synthesis Market Insights, Industry Trend, Forecasts to 2035
Industry: HealthcareSouth Korea DNA Synthesis Market Insights Forecasts to 2035
- The South Korea DNA Synthesis Market Size Was Estimated at USD 87.2 Million in 2024
- The Market Size is Expected to Grow at a CAGR of around 14.79% from 2025 to 2035
- The South Korea DNA Synthesis Market Size is Expected to Reach USD 397.8 Million by 2035
Get more details on this report -
According to a research report published by Spherical Insights and Consulting, The South Korea DNA Synthesis Market Size is anticipated to reach USD 397.8 Million by 2035, growing at a CAGR of 14.79% from 2025 to 2035. The market's expansion can be described as the growing need for DNA synthesis because of its uses in genetic engineering, molecular biology, and clinical diagnostics and treatments. Furthermore, the rising need for research in personalized medicine and medication discovery is anticipated to have a favorable effect on market expansion throughout the forecast period.
Market Overview
The commercial industry devoted to producing and distributing synthetic DNA molecules is included in the DNA synthesis market. This market entails the production of tailored DNA sequences for a range of uses, such as drug discovery, genetic engineering, and molecular biology. The increasing need for these synthetic DNA molecules in medicinal, diagnostic, and research applications is driving the market. Custom DNA sequences for gene therapy, customized vaccinations, and targeted treatments for a range of illnesses, including cancer and genetic abnormalities, can be produced by DNA synthesis. therapeutic discovery is sped up by DNA synthesis, which is essential for finding and creating new medications and therapeutic targets. DNA synthesis is a key component of synthetic biology, which is being actively promoted by governments. This entails establishing regulations that encourage the advancement and commercialization of novel synthetic DNA technologies as well as providing financial assistance for studies into the uses of synthetic biology. The possible abuse of DNA synthesis technology is another issue that governments are concentrating on, and they are taking steps to improve biosecurity and biosafety. Governments can take part in international partnerships to solve biosecurity issues and boost DNA synthesis research.
Report Coverage
This research report categorizes the market for South Korea DNA synthesis market based on various segments and regions forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea DNA synthesis market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea DNA synthesis market.
South Korea DNA Synthesis Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2024 |
Market Size in 2024: | USD 87.2 Million |
Forecast Period: | 2025-2035 |
Forecast Period CAGR 2025-2035 : | CAGR Of 14.79% |
2035 Value Projection: | USD 397.8 Million |
Historical Data for: | 2020-2023 |
No. of Pages: | 249 |
Tables, Charts & Figures: | 104 |
Segments covered: | By Service Type, By Application and By End-use |
Companies covered:: | Bioneer Corporation, Macrogen, NuriBio, Helixmith, SK Bioscience, Samsung Biologics, Lotte Biologics, yuhan Corporation, ToolGen, Inovio Pharmaceuticals, and Others |
Pitfalls & Challenges: | COVID-19 Empact, Challenges, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
The DNA synthesis market is driven by growing demand for personalized medicine, advancements in synthetic biology, and increased research in genomics and biotechnology. Expanding applications in drug development, agriculture, and diagnostics further boost market growth. Rising investments from both public and private sectors, along with technological innovations improving synthesis accuracy and speed, contribute significantly. Additionally, the decreasing cost of DNA synthesis and the rise of CRISPR and gene editing technologies are propelling widespread adoption across pharmaceutical, academic, and industrial research sectors.
Restraining Factors
High costs associated with advanced synthesis technologies can limit accessibility for smaller laboratories and institutions. Additionally, regulatory challenges surrounding the use of synthetic DNA in clinical and environmental applications can slow market expansion. For instance, the U.S. Food and Drug Administration (FDA) has stringent regulations governing gene therapies, which can impact the speed at which new products reach the market. These factors create hurdles that companies must navigate to capitalize on the growing demand for DNA synthesis services.
Market Segmentation
The South Korea DNA Synthesis Market share is classified into service type, application, and end-use.
- The oligonucleotide synthesis segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The South Korean DNA synthesis market is segmented by service type into gene synthesis and oligonucleotide synthesis. Among these, the oligonucleotide synthesis segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. The emphasis on personalized care, genomics research, and comprehending the genetic foundation of illnesses accounts for a greater portion of this market. In molecular biology, genetics, and genomics, oligonucleotides are crucial for processes like PCR, DNA sequencing, and gene expression research.
- The research development segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The South Korea DNA synthesis market is segmented by application into research development and diagnostics. Among these, the research development segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. The expanding application of DNA synthesis to sustain current investigations. Drug development, genetic testing, and molecular biology research all depend on oligonucleotides. Numerous research and development domains, including biopharmaceuticals, synthetic biology, gene synthesis, and genome editing, depend on the DNA synthesis process.
- The biopharmaceutical & diagnostics companies segment dominated share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The South Korea DNA synthesis market is segmented by end-use into biopharmaceutical & diagnostics companies, academics & research institutes, and contract research organizations. Among these, the biopharmaceutical & diagnostics companies segment dominated share in 2024 and is expected to grow at a significant CAGR during the forecast period. Gene synthesis is a common engineering tool used by biopharmaceutical businesses in the market to design and create novel DNA sequences and protein functionalities of interest.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea DNA synthesis market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Bioneer Corporation
- Macrogen
- NuriBio
- Helixmith
- SK Bioscience
- Samsung Biologics
- Lotte Biologics
- yuhan Corporation
- ToolGen
- Inovio Pharmaceuticals
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea DNA synthesis market based on the below-mentioned segments:
South Korea DNA Synthesis Market, By Service Type
- Gene Synthesis
- Oligonucleotide Synthesis
South Korea DNA Synthesis Market, By Application
- Research Development
- Diagnostics
South Korea DNA Synthesis Market, By End-Use
- Biopharmaceutical & Diagnostics Companies
- Academics & Research Institutes
- Contract Research Organizations
Need help to buy this report?